Company profile: Day Zero Diagnostics
1.1 - Company Overview
Company description
- Provider of whole-genome sequencing–based tools and services for clinical pathogen detection, antimicrobial resistance profiling, and outbreak management, including Blood2Bac to enrich bacterial DNA directly from blood; Keynome ID for species identification; Keynome gAST for resistance profiling; MicrohmDB to support machine learning; and epiXact for pathogen relatedness insights for infection control.
Products and services
- Keynome gAST: Machine-learning algorithm that determines antibiotic resistance profiles of pathogens from whole-genome sequencing data, inferring resistance characteristics directly from genomic information
- Keynome ID: Proprietary algorithm that identifies bacterial species in clinical samples using whole-genome sequencing data, generating species-level classifications from genomic reads
- Blood2Bac: Clinical-grade process that enriches bacterial DNA from clinical blood samples, enabling whole-genome sequence coverage of bacterial pathogens directly from blood
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Day Zero Diagnostics
KSQ Therapeutics
HQ: United States
Website
- Description: Provider of CRISPR-enabled drug discovery and development, offering KSQ-4279, a USP1 inhibitor in Phase 1 for advanced solid tumors targeting DNA damage repair; eTIL autologous cell therapies (KSQ-001, KSQ-004) engineered for enhanced tumor killing in solid tumors; the CRISPRomics platform for target identification in oncology and autoimmune diseases; CRISPR2 guide-pairing technology; and the ExPRESS process for eTIL manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full KSQ Therapeutics company profile →
Biomodal
HQ: United Kingdom
Website
- Description: Provider of DNA sequencing tools and multiomic solutions enabling combined genetic and epigenetic analysis from low-input DNA, distinguishing 5mC and 5hmC via duet multiomics solution evoC and +modC, which integrates assay and software for use with existing NGS pipelines; and modality, an analysis package for efficient, scalable 5- and 6-base genome analysis to inform genome organization and gene regulation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biomodal company profile →
Genesis Genetics
HQ: United States
Website
- Description: Provider of preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS), delivering expert laboratory services to respected IVF centers across the country and worldwide for pre-implantation testing of embryos for inherited genetic abnormalities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genesis Genetics company profile →
Parse Biosciences
HQ: United States
Website
- Description: Provider of single-cell sequencing kits and data analysis software for researchers, including Evercode Whole Transcriptome (instrument-free, scalable from thousands to millions of cells), Evercode Immune Profiling (TCR/BCR sequencing), CRISPR Detect (gRNA plus gene expression in up to one million cells), Gene Capture (targeted scRNA-seq panels), and software integrating with NGS platforms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Parse Biosciences company profile →
Checkerspot
HQ: United States
Website
- Description: Provider of biomanufactured performance materials and ingredients, leveraging the WING platform to design at a molecular level. Offerings include High Oleic Algae Oil for industrial and food applications; algae-based Checkerspot Cast PU elastomers and Rigid PU Foam; miDori bioWick textile finish for moisture management; and SpiralMade recycled composite materials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Checkerspot company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Day Zero Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Day Zero Diagnostics
2.2 - Growth funds investing in similar companies to Day Zero Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Day Zero Diagnostics
4.2 - Public trading comparable groups for Day Zero Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →